bf/NASDAQ:ALZN_icon.jpeg

NASDAQ:ALZN

Alzamend Neuro, Inc.

  • Stock

USD

Last Close

2.52

06/11 21:32

Market Cap

3.52M

Beta: -

Volume Today

118.56K

Avg: 184.60K

PE Ratio

−0.38

PFCF: −0.69

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Apr '19
Apr '20
Apr '21
Apr '22
Apr '23
Apr '24
Apr '25
average inventory
-8.11K
-
-8.11K
0%

-
average payables
1.02M
-
716.62K
29.55%
833.22K
16.27%
2.02M
142.01%
1.44M
28.83%

average receivables
239.82K
-
105.24K
56.11%
8.11K
92.30%

-
book value per share
0.00
-
0.01
156.37%
0.02
158.91%
0.15
532.27%
0.03
79.16%
-3.83
12,377.83%

capex per share
-0.00
-
0.67
-
capex to depreciation
-30.00
-
5.91
-
capex to operating cash flow
0.02
-
-0.05
-
capex to revenue
cash per share
0.00
-
0.00
109.52%
0.02
2,158.48%
0.16
594.89%
0.05
66.60%
0.56
954.36%

days of inventory on hand

-
days payables outstanding

-
days sales outstanding
debt to assets
0.12
-
debt to equity
0.17
-
dividend yield
earnings yield
-0.00
-
-0.00
10.60%
-0.00
25.10%
-0.14
2,907.53%
-0.29
110.37%
-2.07
620.15%
-1.69
18.47%
enterprise value
1.20B
-
1.21B
1.13%
1.14B
5.51%
76.81M
93.29%
46.67M
39.24%
4.43M
90.50%

enterprise value over ebitda
-239.20
-
-273.88
14.50%
-231.30
15.55%
-6.24
97.30%
-3.14
49.60%
-0.45
85.80%

ev to operating cash flow
-1.15K
-
-516.55
54.94%
-422.18
18.27%
-11.61
97.25%
-5.23
54.96%
-0.54
89.75%

ev to sales
free cash flow per share
-0.01
-
-0.03
121.91%
-0.03
22.19%
-0.08
136.22%
-0.09
21.31%
-12.22
13,258.77%
-15.24
24.64%
free cash flow yield
-0.00
-
-0.00
121.91%
-0.00
22.19%
-0.07
3,026.38%
-0.17
132.89%
-1.72
898.24%
-2.56
49.19%
graham net net
-0.01
-
-0.01
19.36%
0.01
244.45%
0.14
1,089.52%
0.02
83.92%
-4.21
18,189.06%

graham number
0.07
-
0.10
51.39%
0.18
79.97%
0.69
279.04%
0.33
52.21%
35.62
10,777.73%
income quality
0.21
-
0.53
147.45%
0.54
1.03%
0.54
0.44%
0.60
12.10%
0.83
38.62%
1.45
74.99%
intangibles to total assets
0
-
0
0
0
0
0
0
interest coverage
-31.18
-
-264.80
749.19%
-1.93K
629.22%
983.83
150.95%
-249.42
125.35%
interest debt per share
0.01
-
0.00
91.02%
0.00
84.88%
-0.01
19,005.89%

inventory turnover
invested capital
0.17
-

-
market cap
1.20B
-
1.21B
1.14%
1.15B
5.38%
90.88M
92.07%
51.81M
42.99%
4.81M
90.72%
2.68M
44.33%
net current asset value
316.92K
-
821.71K
159.28%
2.01M
144.97%
13.25M
558.17%
2.97M
77.62%
-2.77M
193.42%

net debt to ebitda
0.01
-
0.02
139.91%
0.32
1,477.88%
1.14
254.63%
0.35
69.68%
0.04
89.07%

net income per share
-0.05
-
-0.05
10.60%
-0.06
25.10%
-0.14
127.24%
-0.15
9.58%
-14.70
9,537.29%
-10.02
31.88%
operating cash flow per share
-0.01
-
-0.03
121.91%
-0.03
22.19%
-0.07
132.47%
-0.09
23.26%
-12.22
13,258.77%
-14.57
19.20%
payables turnover
receivables turnover
research and ddevelopement to revenue
return on tangible assets
-3.24
-
-2.42
25.19%
-1.79
26.28%
-0.85
52.17%
-2.52
194.32%
-15.75
526.24%
revenue per share
roe
-15.34
-
-5.35
65.13%
-2.59
51.68%
-0.93
64.06%
-4.89
425.82%
3.83
178.49%
roic
-15.33
-
-5.37
64.99%
-2.17
59.49%
-0.93
57.42%
-4.88
427.36%
3.83
178.45%
sales general and administrative to revenue
shareholders equity per share
0.00
-
0.01
156.37%
0.02
158.91%
0.15
532.27%
0.03
79.16%
-3.83
12,377.83%

stock based compensation to revenue
tangible asset value
316.92K
-
821.71K
159.28%
2.01M
144.97%
13.35M
563.28%
3.05M
77.19%
-2.59M
185.18%

tangible book value per share
0.00
-
0.01
156.37%
0.02
158.91%
0.15
532.27%
0.03
79.16%
-3.83
12,377.83%

working capital
316.92K
-
821.71K
159.28%
2.01M
144.97%
13.25M
558.17%
2.97M
77.62%
-2.77M
193.42%

All numbers in USD (except ratios and percentages)